Medical-Isotope Flight-and-Decay Recovery Leader

The mandate

The network makes short-lived diagnostic isotope products against fixed reactor or cyclotron windows, yet production planning, quality release, airline uplift and hospital appointments are managed as separate clocks. Two recent missed connections left technically conforming batches below usable activity on arrival, displaced patient lists and forced hospitals to improvise scarce alternatives. The executive committee wants one accountable supply authority who can value every remaining hour, distinguish a recoverable transport exception from a lost clinical promise and stop commercial optimism overriding physical decay.

The leader will chair a twice-daily batch control around irradiation, synthesis, release, package close, tender, uplift, border release and calibrated hospital receipt. Each live batch will carry expected activity at named hand-offs, the last useful departure, alternate airport and a decision owner. A threatened uplift must be acknowledged within fifteen minutes and receive a continue, reroute, remake or cancel recommendation within forty-five, without encouraging unsafe dispatch or asking Quality to abbreviate release.

The appointment lasts six months: four weeks to stabilise the daily flight board, two isotope production cycles to reset carrier and hospital promises, and a final month to prove the permanent supply lead can run the controls. The term cannot roll because an irradiation slot moves or a licence variation remains open. Handover requires audited batch histories, route playbooks, hospital-slot rules, trained deputies and evidence that avoidable decay loss has fallen without gaming cancelled-batch definitions.

Authority covers capacity reservation within approved budgets, carrier escalation, alternative uplift, inventory priority and the sequence in which commercial commitments enter production. The leader may cancel a logistics plan that cannot deliver minimum usable activity. The Qualified Person retains batch release; radiation protection owns exposure controls; licensed shippers approve packages and declarations; nuclear-medicine physicians decide patient use. No recovery target permits alteration of calibration data, activity specification, clinical priority or dangerous-goods compliance.

Commercial network redesign, isotope portfolio strategy, clinical pathway change, reactor investment, facility licensing and permanent airline procurement sit outside scope. All carrier, handler, packaging, reactor, cyclotron, hospital and competing-producer relationships must be declared. Patient identifiers stay inside controlled systems. Any safety event, suspect package or custody break moves immediately to the responsible licensed function rather than being contained as a service metric.

Why this seat is open

Ordinary air-freight optimisation treats an hour as a service variable; isotope supply treats it as disappearing product. The company needs an executive who has coordinated production physics, validated packaging, release evidence, cargo cut-offs and a hospital’s actual administration window at once. This is not a generic healthcare-courier brief: the decisive output is a feasible activity-at-use promise for each manufactured batch.

What you will own

• Establish the activity-at-handoff model linking irradiation yield, synthesis loss, release time, transport duration, calibration point and hospital-use threshold.
• Run the live batch board and make documented remake, reroute, uplift, allocation or cancellation calls within defined financial authority.
• Recontract carrier and handler service around acceptance cut-offs, dangerous-goods capability, weekend coverage, priority recovery and named escalation paths.
• Align hospital appointment release with credible batch milestones, preventing patient scheduling from outrunning production or border evidence.
• Qualify operational alternates across airports, road feeders, package stock, drivers and customs brokers without bypassing licensed approvals.
• Reconcile planned and actual activity loss by cause, exposing avoidable dwell, optimistic connection assumptions and false on-time measures.
• Transfer route playbooks, decision thresholds, supplier actions, batch histories and a tested command rhythm to permanent management.

Candidate qualifications

• Led radiopharmaceutical or medical-isotope supply across irradiation, synthesis, quality release, radioactive packaging, air carriage and hospital receipt.
• Has recovered time-critical batches after flight disruption while protecting activity evidence, dangerous-goods controls and clinical communication.
• Understands half-life, activity calibration, usable-at-administration thresholds, package categories, carrier acceptance and cross-border radioactive-material documentation.
• Has held executive allocation authority without trespassing on Qualified Person, radiation-protection, shipper, customs or physician decisions.
• Can interrogate production and transport timestamps, distinguish physical decay from process delay and build defensible loss causation.
• Has developed deputies and permanent controls in a regulated network rather than remaining its indispensable emergency dispatcher.

Non-negotiables

• Can be based in Prague within three weeks and travel to production, airport and hospital interfaces at short notice.
• Brings direct isotope or radiopharmaceutical operating experience; parcel, pharmaceutical or airline logistics alone is insufficient.
• Will declare reactor, producer, carrier, handler, package-provider, hospital and competitor relationships before receiving network data.
• Accepts no batch-release, radiation-safety, package-certification, customs, prescribing or patient-administration authority.

1. 49 words maximum. Describe a batch you cancelled because remaining activity made the apparent transport recovery clinically unusable.
2. 49 words maximum. Which timestamp most often exposes hidden decay loss between release and hospital receipt?
3. 49 words maximum. What reactor, carrier, hospital or competing-producer relationship could require your recusal?

---